Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan

Clinical trial NCT02239380 · COMPLETED

Trial details

NCT number: NCT02239380
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Status Epilepticus

Start date: 2014-11-01
Primary completion: 2016-08-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.